Skip to main content
Get Alerts

Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to September 2026.

37,061
Total recall recordsAll FDA and USDA recalls in Public Health Trace
9,786
Class I recallsReasonable probability of serious health consequences
24,313
Class II recallsTemporary or medically reversible health consequences
2,876
Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls
Most common hazardLack of Assurance of Sterility 2,072 recalls
Newest recallhttps://www.fsis.usda.gov/recalls-alerts/el-eden-import-distributor-corp-recalls-ineligible-pork-cracklings-products-importedPublished September 9, 2026
Most affected stateHawaii 200 recalls mention this state

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters
Recall details
Location
Date range
Sort results
Clear filters
Metric
View
Recalls announced by month (Year to date)

A chart of recalls grouped by month.

Download CSV

Source: FDA and USDA public dataLast updated

Summary (Year to date)

  • 1,527 recalls have been announced year to date.
  • Aug 2026 was 24% lower than the previous complete period (Jul 2026: 240).
  • The highest complete period was Jun 2026 (297).
  • Sep 2026 is incomplete and not included in the figures above.
  • Complete data
  • Incomplete
Recalls by class

A bar chart of the total number of recalls in this dataset by recall class.

Recalls by class
ClassRecalls
Class II24,313
Class I9,786
Class III2,876
Not Yet Classified2
Download CSV
Recalls by class
ClassRecalls
Class II24,313
Class I9,786
Class III2,876
Not Yet Classified2

Showing 2,141–2,160 of 17,299 recalls

FDA Recall Ongoing Historical recordClass II

Diltiazem Hydrochloride Extended-Release Capsules, USP 120 mg, Twice-a-Day Dosage, 100 Capsules per bottle, Rx Only, Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ, 07430, Product of India, NDC 68462-562-01.

by Glenmark Pharmaceuticals Inc., USA

Reason
Failed Dissolution Specifications
Published
May 1, 2024
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Ipratropium Bromide and Albuterol Sulfate Inhalation Solution USP, 0.5 mg & 3mg/3mL unit-dose vials, packaged in carton containing 30 vials ( 6 pouches of 5 - 3 mL vials), Rx only, Manufactured by: Cipla Ltd., Indore SEZ, Pithampur, India, Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059, NDC 69097-173-53

by Cipla USA, Inc.

Reason
Short fill: Complaints received of less fill volume in respule and few drops of liquid observed in the intact pouch.
Published
May 1, 2024
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

ForeverMen Natural Energy Boost Capsules, packaged in a box containing a 10-count blister card.

by FA Online Inc

Reason
Marketed Without an Approved NDA/ANDA: Product was found to contain undeclared sildenafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this unapproved drug.
Published
May 1, 2024
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass III

Abilify (aripiprazole), 30 mg tablets, packaged in 30 count bottles, RX only, Otsuka America Pharmaceutical, Inc., NDC 59148-011-13

by Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd.

Reason
Cross Contamination with Other Products
Published
May 1, 2024
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass III

Abilify (aripiprazole), 15 mg tablets, packaged in 30 count bottles, RX only, Otsuka America Pharmaceutical, Inc., NDC 59148-009-13

by Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd.

Reason
Cross Contamination with Other Products
Published
May 1, 2024
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass III

Abilify (aripiprazole), 10 mg tablets, packaged in a) 30 count bottles (NDC 59148-008-13) and b) 7 count blister packs (NDC 59148-008-95), RX only, Otsuka America Pharmaceutical, Inc.

by Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd.

Reason
Cross Contamination with Other Products
Published
May 1, 2024
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass III

Abilify (aripiprazole), 5 mg tablets, packaged in 30 count bottles, RX only, Otsuka America Pharmaceutical, Inc., NDC 59148-007-13

by Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd.

Reason
Cross Contamination with Other Products
Published
May 1, 2024
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

FUL-GLO, Fluorescein Sodium Ophthalmic Strips USP 1 mg, 100 sterile strips per carton, Manufactured for: Akorn, Inc., Lake Forest, IL 60045, NDC 17478-404-01.

by Nomax Inc

Reason
Failed Impurities/Degradation Specifications: The Active Pharmaceutical Ingredient (API) used in the product is not being manufactured to the current USP monograph in regard to Unspecified Impurities.
Published
May 1, 2024
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

FUL-GLO, Fluorescein Sodium Sterile Ophthalmic Strips USP (0.6 mg Fluorescein), 300 sterile strips per carton, Manufactured for: Akorn, Inc., Lake Forest, IL 60045, NDC 17478-403-03.

by Nomax Inc

Reason
Failed Impurities/Degradation Specifications: The Active Pharmaceutical Ingredient (API) used in the product is not being manufactured to the current USP monograph in regard to Unspecified Impurities.
Published
May 1, 2024
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

GloStrips, Fluorescein Sodium Ophthalmic Strips USP (1.0 mg Fluorescein), Rx Only, 100 Sterile Strips per carton, Nomax, Inc., St. Louis, MO 63123, NDC 51801-009-40.

by Nomax Inc

Reason
Failed Impurities/Degradation Specifications: The Active Pharmaceutical Ingredient (API) used in the product is not being manufactured to the current USP monograph in regard to Unspecified Impurities.
Published
May 1, 2024
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

GloStrips, Fluorescein Sodium Ophthalmic Strips USP (0.6 mg Fluorescein), Rx Only, a) 100 strips per carton, NDC 51801-003-40; b) 300 strips per carton, NDC 51801-003-50, Nomax, Inc., St. Louis, MO 63123.

by Nomax Inc

Reason
Failed Impurities/Degradation Specifications: The Active Pharmaceutical Ingredient (API) used in the product is not being manufactured to the current USP monograph in regard to Unspecified Impurities.
Published
May 1, 2024
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Eyesaline, Saline Eyewash Solution, Cartridge for Fendall 2000, Net contents: 7.9 gal per cartridge, Sperian Eye & Face Protection, Inc., 825 East Highway 151, Platteville, WI 53818. NDC: 0498-0631-37

by HONEYWELL INC

Reason
CGMP Deviations
Published
May 1, 2024
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass I

Aruba Aloe Hand Sanitizer Gel, 80% Alcohol, 12 fl oz (355 mL) plastic bottle, Manufactured in Aruba by Aruba Aloe Balm Inc., Pitastraat 115, Aruba, Dutch Caribbean. UPC 0 82252 03300 5

by Aruba Aloe Balm N.V.

Reason
Chemical Contamination: Product manufactured with ethanol API that contains methanol
Published
May 1, 2024
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass I

Alcoholada Gel, Pain Relieving Gel, 0.5% Lidocaine Hydrochloride, packaged in (a) 8.5 fl oz (251 mL) plastic bottle UPC 0 82252 03120 9 (b) 2.2 fl oz (65 mL) plastic bottle, UPC 0 82252 34030 1 , Manufactured in Aruba by Aruba Aloe Balm Inc., Pitastraat 115, Aruba, Dutch Caribbean.

by Aruba Aloe Balm N.V.

Reason
Chemical Contamination: Product manufactured with ethanol API that contains methanol
Published
May 1, 2024
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass I

HONEY MANUKA BUNNY LOVE, 12g, All Natural Sexual Enhancement, UPC: N/A

by Pyramids Wholesale Inc.

Reason
Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.
Published
May 1, 2024
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass I

ALPHASTRIP MALE PERFORMANCE ENHANCER, The fastest acting sublingual, Serving Size (1 strip), Distributed by: GALT INT'L

by Pyramids Wholesale Inc.

Reason
Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.
Published
May 1, 2024
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass I

The GOAT SUBLINGUAL STRIP, MALE ENHANCEMENT, 2 Pack, Distributed by Hombres LLC, 130 Maccormick Ave, Suite 105, Costa Mesa, A, UPC 6 61631 26363 1.

by Pyramids Wholesale Inc.

Reason
Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.
Published
May 1, 2024
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass I

SILVERBACK XXX POWER MALE ENHANCEMENT, 2 fl. oz., UPC 8 700470 032762

by Pyramids Wholesale Inc.

Reason
Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.
Published
May 1, 2024
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass I

libigrow RED DRAGON+, Maximum Strength Formula, 2 capsules per box, UPC 7 05105 83073 5.

by Pyramids Wholesale Inc.

Reason
Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.
Published
May 1, 2024
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass I

GoHARD 25000, Male Sexual Enhancement, Honey, 100% Natural, UPC: N/A.

by Pyramids Wholesale Inc.

Reason
Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.
Published
May 1, 2024
Distribution
Nationwide

View recall →

Data last updated:

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.